Each project will receive $100,000. The Innovation Discovery Grants program has distributed more than $3.5 million in grants since its inception in 2014.
Below is an overview of the five innovation projects that received grants:
- Brain Penetrant AAV Vectors for CNS Gene Therapy: Fengfeng Bei, PhD, a principal investigator at Brigham and Women’s Hospital’s neurosurgery department, is leading a project seeking to optimize adeno-associated virus gene delivery technology to strengthen its ability to treat diseases in the central nervous system.
- Commensal Papillomavirus Vaccine Development for Skin Cancer Therapy: Shawn Demehri, MD, PhD, a principal investigator at Massachusetts General Hospital’s Center for Cancer Immunology and Cutaneous Biology Research, is leading a project to use an HPV vaccine strategy to treat squamous cell carcinoma.
- Harnessing Neutrophil Plasticity for the Treatment of Cancer: Tanya Mayadas, PhD, a senior scientist at Brigham and Women’s Hospital’s pathology department, is leading a project seeking to improve cancer treatment by activating T cells through an antigen-antibody conjugate.
- A Clinically Applicable AI Toolbox for Dystonia Diagnosis: Kristina Simonyan, MD, PhD, the director of laryngology research at Massachusetts Eye and Ear, is leading a project focusing on developing a machine learning model for automatic dystonia diagnosis.
- Addressing the Need for Early, Accurate Diagnosis of Parkinson’s Disease: A New PET Radiotracer: Anna Sromek, PhD, the associate director of McLean Hospital’s medicinal chemistry laboratory, is leading a project to discover a reliable biomarker or imaging technique to accurately diagnose Parkinson’s disease earlier.
More articles on digital transformation:
Genomics company Color gains unicorn status
5 recent health IT, innovation partnerships
Why CIOs are gaining more influence in front-office decision making in 2021
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
